301 related articles for article (PubMed ID: 12629649)
1. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
Koraka P; Murgue B; Deparis X; Setiati TE; Suharti C; van Gorp EC; Hack CE; Osterhaus AD; Groen J
J Med Virol; 2003 May; 70(1):91-8. PubMed ID: 12629649
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.
Koraka P; Suharti C; Setiati TE; Mairuhu AT; Van Gorp E; Hack CE; Juffrie M; Sutaryo J; Van Der Meer GM; Groen J; Osterhaus AD
J Clin Microbiol; 2001 Dec; 39(12):4332-8. PubMed ID: 11724841
[TBL] [Abstract][Full Text] [Related]
3. Serological markers during dengue 3 primary and secondary infections.
Vázquez S; Pérez AB; Ruiz D; Rodríguez R; Pupo M; Calzada N; González L; González D; Castro O; Serrano T; Guzmán MG
J Clin Virol; 2005 Jun; 33(2):132-7. PubMed ID: 15911428
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune response of dengue hemorrhagic fever cases in children from Tegucigalpa, Honduras.
De Rivera IL; Parham L; Murillo W; Moncada W; Vazquez S
Am J Trop Med Hyg; 2008 Aug; 79(2):262-6. PubMed ID: 18689634
[TBL] [Abstract][Full Text] [Related]
5. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity.
Koraka P; Murgue B; Deparis X; Van Gorp EC; Setiati TE; Osterhaus AD; Groen J
J Med Virol; 2004 Mar; 72(3):445-50. PubMed ID: 14748068
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections.
Vázquez S; Cabezas S; Pérez AB; Pupo M; Ruiz D; Calzada N; Bernardo L; Castro O; González D; Serrano T; Sanchez A; Guzmán MG
Int J Infect Dis; 2007 May; 11(3):256-62. PubMed ID: 16914345
[TBL] [Abstract][Full Text] [Related]
7. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
[TBL] [Abstract][Full Text] [Related]
8. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
9. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Endy TP; Raengsakulrach B; Rothman AL; Ennis FA; Nisalak A
J Infect Dis; 2000 Jan; 181(1):2-9. PubMed ID: 10608744
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia.
Khan NA; Azhar EI; El-Fiky S; Madani HH; Abuljadial MA; Ashshi AM; Turkistani AM; Hamouh EA
Acta Trop; 2008 Jan; 105(1):39-44. PubMed ID: 17983609
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G antibody response in children and adults with acute dengue 3 infection.
Vazquez S; Acosta N; Ruiz D; Calzada N; Alvarez AM; Guzman MG
J Virol Methods; 2009 Jul; 159(1):6-9. PubMed ID: 19442837
[TBL] [Abstract][Full Text] [Related]
12. Severe dengue virus infection in travelers: risk factors and laboratory indicators.
Wichmann O; Gascon J; Schunk M; Puente S; Siikamaki H; Gjørup I; Lopez-Velez R; Clerinx J; Peyerl-Hoffmann G; Sundøy A; Genton B; Kern P; Calleri G; de Górgolas M; Mühlberger N; Jelinek T;
J Infect Dis; 2007 Apr; 195(8):1089-96. PubMed ID: 17357044
[TBL] [Abstract][Full Text] [Related]
13. Studies on dengue and dengue haemorrhagic fever (DHF) in West Bengal State, India.
Hati AK
J Commun Dis; 2006 Mar; 38(2):124-9. PubMed ID: 17370674
[TBL] [Abstract][Full Text] [Related]
14. An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi.
Aggarwal A; Chandra J; Aneja S; Patwari AK; Dutta AK
Indian Pediatr; 1998 Aug; 35(8):727-32. PubMed ID: 10216566
[TBL] [Abstract][Full Text] [Related]
15. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
[TBL] [Abstract][Full Text] [Related]
16. Co-circulations of two genotypes of dengue virus in 2006 out-break of dengue hemorrhagic fever in Karachi, Pakistan.
Khan E; Hasan R; Mehraj V; Nasir A; Siddiqui J; Hewson R
J Clin Virol; 2008 Oct; 43(2):176-9. PubMed ID: 18639489
[TBL] [Abstract][Full Text] [Related]
17. Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections.
Chanama S; Anantapreecha S; A-nuegoonpipat A; Sa-gnasang A; Kurane I; Sawanpanyalert P
J Clin Virol; 2004 Nov; 31(3):185-9. PubMed ID: 15465410
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections.
Mairuhu AT; Peri G; Setiati TE; Hack CE; Koraka P; Soemantri A; Osterhaus AD; Brandjes DP; van der Meer JW; Mantovani A; van Gorp EC
J Med Virol; 2005 Aug; 76(4):547-52. PubMed ID: 15977234
[TBL] [Abstract][Full Text] [Related]
19. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
[TBL] [Abstract][Full Text] [Related]
20. Secondary dengue virus type 4 infections in Vietnam.
Buchy P; Vo VL; Bui KT; Trinh TX; Glaziou P; Le TT; Le VL; Bui TC
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):178-85. PubMed ID: 15906664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
